SearchDictionaryMobileLogin

Lymphatic Diseases (Lymphadenopathy)

1958  relevant articles (90 outcomes, 69 trials/studies) found for this Disease

Description: Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.

Also Known As:
Lymphadenopathy; Disease, Lymphatic; Diseases, Lymphatic; Lymphatic Disease; Lymphatism; Status Lymphaticus

Relationship Network

Disease Context: Research Results

Related Diseases

1. Splenomegaly
2. Lymphoma (Lymphomas)
3. Fever (Fevers)
4. Hypergammaglobulinemia (Hyperimmunoglobulinemia)
5. Proteinuria

Experts

1. Rodríguez, Xavier: 1 article (09/2008)
2. Tortajada, Lidia: 1 article (09/2008)
3. González, Guadalupe: 1 article (09/2008)
4. Sentís, Melcior: 1 article (09/2008)
5. Ganau, Sergi: 1 article (09/2008)
6. Kocjan, G I: 1 article (08/2008)
7. Austin, O: 1 article (08/2008)
8. Lowe, S M: 1 article (08/2008)
9. Miller, R F: 1 article (08/2008)
10. Edwards, S G: 1 article (08/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Lymphatic Diseases:
1. Prednisolone (Predate)FDA LinkGeneric
2. DNA (Deoxyribonucleic Acid)IBA
3. AntibodiesIBA
4. AutoantibodiesIBA
5. Immunoglobulin G (IgG)IBA
6. Hemoglobins (Hemoglobin)IBA
06/15/1991 - "No significant differences were observed between conventional and aberrant ALL in the distribution of sex, age, leukocyte count, hemoglobin concentration, platelet count, blast count, French-American-British (FAB) type, lymphadenopathy, organomegaly, rate or duration of remission, or survival. "
04/15/1980 - "Factors found to be independently associated with an increased risk of testicular relapse during maintained remission included pretreatment lymphadenopathy, and to a lesser extent, initial hemoglobin level and initial platelet count. "
04/01/2000 - "Univariate analyses showed that presenting features were similar between My+B and My-B with regard to age, sex, race, FAB morphology, white cell count, hemoglobin level, platelet count, liver/spleen size, central nervous system or mediastinal involvement, presence of lymphadenopathy, and proportion of blast cells detected in the marrow. "
02/01/1986 - "However, the E-PT+ patients were also significantly different from the more traditionally-defined E+ patients in that they had lower WBCs and hemoglobin levels, and less frequent lymphadenopathy or mediastinal mass. "
10/01/2000 - "Complete remission is defined as the condition when signs of activity of the disease are absent, splenomegaly and lymphadenopathy are absent, the hemoglobin concentration is > or = 120 g/l, the absolute number of granulocytes is > or = 1.5 x 10(9)/l and the number of thrombocytes is > or = 100 x 10(9)/l. "
Order ALL the reference details at left...
7. Immunoglobulins (Immunoglobulin)IBA
8. Prednisone (Sone)FDA LinkGeneric
9. Cyclophosphamide (Cytoxan)FDA LinkGeneric
10. Dexamethasone (Maxidex)FDA LinkGeneric

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Aftercare (After-Treatment)
3. Amputation
4. Renal Dialysis (Hemodialysis)
5. X-Ray Film

Best Treatments:
Research Summary Report
on Lymphatic Diseases

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 90 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>